News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Fromkin Andrew J.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 04/14/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/12/2022 |
4
| Fromkin Andrew J. (Director) has filed a Form 4 on Immunovant, Inc.|
Txns:
| Granted 21,726 shares
@ $0
Granted 71,492 options to buy
@ $7.94, valued at
$567.6k
|
|
| 08/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/18/2020 |
4
| Fromkin Andrew J. (Director) has filed a Form 4 on Immunovant, Inc.|
Txns:
| Granted 24,700 shares
@ $0
Granted 37,000 options to buy
@ $19.01, valued at
$703.4k
|
|
| 12/20/2019 |
4
| Fromkin Andrew J. (Director) has filed a Form 4 on Immunovant, Inc.|
Txns:
| Granted 77,181 options to buy
@ $8.43, valued at
$650.6k
|
|
| 12/20/2019 |
3
| Fromkin Andrew J. (Director) has filed a Form 3 on Immunovant, Inc. |
| 11/03/2016 |
4
| Fromkin Andrew J. (Director) has filed a Form 4 on Tobira Therapeutics, Inc.|
Txns:
| Unknown transaction of 11 shares
@ $0
Unknown transaction of 5 shares
@ $0
Disposed/sold 5,666 options to buy
@ $58.23, valued at
$329.9k
Disposed/sold 15,500 options to buy
@ $16.52, valued at
$256.1k
Disposed/sold 17,778 options to buy
@ $7.91, valued at
$140.6k
Disposed/sold 17,695 options to buy
@ $8.19, valued at
$144.9k
|
|
| 01/14/2016 |
4
| Fromkin Andrew J. (Director) has filed a Form 4 on Tobira Therapeutics, Inc.|
Txns:
| Granted 17,778 options to buy
@ $7.91, valued at
$140.6k
|
|
| 07/13/2015 |
4
| Fromkin Andrew J. (Director) has filed a Form 4 on Tobira Therapeutics, Inc.|
Txns:
| Granted 15,500 options to buy
@ $16.52, valued at
$256.1k
|
|
| 01/05/2015 |
4
| Fromkin Andrew J. (Director) has filed a Form 4 on Regado Biosciences Inc|
Txns:
| Granted 159,261 options to buy
@ $0.91, valued at
$144.9k
|
|
| 06/16/2014 |
4
| Fromkin Andrew J. (Director) has filed a Form 4 on Regado Biosciences Inc|
Txns:
| Granted 51,000 options to buy
@ $6.47, valued at
$330k
|
|
| 11/18/2013 |
4
| Fromkin Andrew J. (President & CEO) has filed a Form 4 on Radius Health, Inc.|
Txns:
| Granted 2,427,133 options to buy
@ $3.45, valued at
$8.4M
|
|
| 04/14/2011 |
4
| Fromkin Drew J (CEO, President) has filed a Form 4 on CLINICAL DATA INC|
Txns:
| Unknown transaction of 9,405 shares
@ $30, valued at
$282.2k
Disposed/sold 75,000 options to buy
@ $11.93, valued at
$894.8k
Disposed/sold 225,000 options to buy
@ $12.37, valued at
$2.8M
Disposed/sold 231,773 options to buy
@ $12.37, valued at
$2.9M
Disposed/sold 7,955 options to buy
@ $10.73, valued at
$85.4k
Disposed/sold 120,000 options to buy
@ $14.99, valued at
$1.8M
Disposed/sold 100,000 options to buy
@ $16.95, valued at
$1.7M
Disposed/sold 100,000 options to buy
@ $8.78, valued at
$878k
Disposed/sold 110,000 options to buy
@ $18.39, valued at
$2M
Granted 110,000 options to buy
@ $16.54, valued at
$1.8M
|
|
| 12/23/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/22/2009 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/23/2008 |
4
| Fromkin Drew J (CEO, President) has filed a Form 4 on CLINICAL DATA INC |
|
|